Phase 2 Study of Copanlisib in Combination With Nivolumab in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Primary Mediastinal Large B-Cell Lymphoma
Phase of Trial: Phase II
Latest Information Update: 06 Nov 2019
Price : $35 *
At a glance
- Drugs Copanlisib (Primary) ; Nivolumab (Primary)
- Indications Diffuse large B cell lymphoma
- Focus Therapeutic Use
- 06 Nov 2019 Trial design released in the 61st Annual Meeting and Exposition of the American Society of Hematology
- 30 Sep 2019 Status changed from suspended to recruiting.
- 05 Sep 2019 Status changed from recruiting to suspended.